Fixed fee system for property mutation to ease financial burden on buyers

Prayagraj: Prayagraj Municipal Corporation has provided major relief to property owners in the city by introducing a ...
CURE

FDA Fully Approves Braftovi Combo for BRAF V600E Metastatic Colorectal Cancer

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

Ascendis wins US approval for therapy for children with dwarfism

The U.S. Food and Drug Administration on Friday approved Ascendis Pharma's once-weekly therapy for children with a rare genetic disorder that causes dwarfism, the company said.

FDA approves HERNEXEOS(R), the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option

The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

Cancer-linked herbicide in the spotlight after controversial order: 'Toxic by design'

HHS Secretary Kennedy supports Trump's glyphosate order while acknowledging pesticides "are toxic by design" and pose risks to Americans' health.

FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...
El Adelantado de Segovia

Goodbye to the idea that radiation only affects those who receive it—a study reveals clustered mutations that can be passed on to future generations

Since the Chernobyl nuclear disaster in 1986, something has concerned scientists: can exposure to radiation leave marks in someone’s DNA that are passed on to ...
CURE

FDA Approves Hernexeos for HER2-Mutant Non-Small Cell Lung Cancer

The U.S. Food and Drug Administration (FDA) has approved Hernexeos (zongertinib) for adults with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have specific HER2 ...

Cancer-linked pesticide in the spotlight after controversial order: 'Toxic by design'

HHS Secretary Kennedy supports Trump's glyphosate order while acknowledging pesticides "are toxic by design" and pose risks ...

New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors

(“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced that results from the ...
Fierce Pharma

Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod

The nod allows Hernexeos (zongertinib) to be used as an initial treatment option for NSCLC with HER2-activating mutations in ...

Cancer rates are rising in CT young people. Here’s what doctors say and what you should know

Breta Hasimi struggled to speak when she received the diagnosis of triple-negative breast cancer, one of the most aggressive ...